Literature DB >> 23294136

GABAA , NMDA and mGlu2 receptors tonically regulate inhibition and excitation in the thalamic reticular nucleus.

John W Crabtree1, David Lodge, Zafar I Bashir, John T R Isaac.   

Abstract

Traditionally, neurotransmitters are associated with a fast, or phasic, type of action on neurons in the central nervous system (CNS). However, accumulating evidence indicates that γ-aminobutyric acid (GABA) and glutamate can also have a continual, or tonic, influence on these cells. Here, in voltage- and current-clamp recordings in rat brain slices, we identify three types of tonically active receptors in a single CNS structure, the thalamic reticular nucleus (TRN). Thus, TRN contains constitutively active GABAA receptors (GABAA Rs), which are located on TRN neurons and generate a persistent outward Cl(-) current. When TRN neurons are depolarized, blockade of this current increases their action potential output in response to current injection. Furthermore, TRN contains tonically active GluN2B-containing N-methyl-D-aspartate receptors (NMDARs). These are located on reticuloreticular GABAergic terminals in TRN and generate a persistent facilitation of vesicular GABA release from these terminals. In addition, TRN contains tonically active metabotropic glutamate type 2 receptors (mGlu2Rs). These are located on glutamatergic cortical terminals in TRN and generate a persistent reduction of vesicular glutamate release from these terminals. Although tonically active GABAA Rs, NMDARs and mGlu2Rs operate through different mechanisms, we propose that the continual and combined activity of these three receptor types ultimately serves to hyperpolarize TRN neurons, which will differentially affect the output of these cells depending upon the current state of their membrane potential. Thus, when TRN cells are relatively depolarized, their firing in single-spike tonic mode will be reduced, whereas when these cells are relatively hyperpolarized, their ability to fire in multispike burst mode will be facilitated.
© 2013 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294136      PMCID: PMC4243027          DOI: 10.1111/ejn.12098

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  88 in total

1.  GABA uptake regulates cortical excitability via cell type-specific tonic inhibition.

Authors:  Alexey Semyanov; Matthew C Walker; Dimitri M Kullmann
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

2.  Reduction of excitatory postsynaptic responses by persistently active metabotropic glutamate receptors in the hippocampus.

Authors:  Attila Losonczy; Peter Somogyi; Zoltan Nusser
Journal:  J Neurophysiol       Date:  2003-04       Impact factor: 2.714

3.  New intrathalamic pathways allowing modality-related and cross-modality switching in the dorsal thalamus.

Authors:  John W Crabtree; John T R Isaac
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

4.  Contrary roles of kainate receptors in transmitter release at corticothalamic synapses onto thalamic relay and reticular neurons.

Authors:  Mariko Miyata; Keiji Imoto
Journal:  J Physiol       Date:  2009-01-05       Impact factor: 5.182

5.  Receptors with different affinities mediate phasic and tonic GABA(A) conductances in hippocampal neurons.

Authors:  Brandon M Stell; Istvan Mody
Journal:  J Neurosci       Date:  2002-05-10       Impact factor: 6.167

6.  NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity.

Authors:  Rylan S Larsen; Rebekah J Corlew; Maile A Henson; Adam C Roberts; Masayoshi Mishina; Masahiko Watanabe; Stuart A Lipton; Nobuki Nakanishi; Isabel Pérez-Otaño; Richard J Weinberg; Benjamin D Philpot
Journal:  Nat Neurosci       Date:  2011-02-06       Impact factor: 24.884

7.  Target-dependent control of synaptic inhibition by endocannabinoids in the thalamus.

Authors:  Yan-Gang Sun; Chia-Shan Wu; Hui-Chen Lu; Michael Beierlein
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

8.  Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotype.

Authors:  Laura Ceolin; Sriharsha Kantamneni; Gareth R I Barker; Lydia Hanna; Laura Murray; E Clea Warburton; Emma S J Robinson; James A Monn; Stephen M Fitzjohn; Graham L Collingridge; Zuner A Bortolotto; David Lodge
Journal:  J Neurosci       Date:  2011-05-04       Impact factor: 6.167

Review 9.  Extrasynaptic GABAA receptors: form, pharmacology, and function.

Authors:  Delia Belelli; Neil L Harrison; Jamie Maguire; Robert L Macdonald; Matthew C Walker; David W Cope
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

10.  Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

Authors:  Stephen G Brickley; Istvan Mody
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

View more
  10 in total

1.  TRPM4 Conductances in Thalamic Reticular Nucleus Neurons Generate Persistent Firing during Slow Oscillations.

Authors:  John J O'Malley; Frederik Seibt; Jeannie Chin; Michael Beierlein
Journal:  J Neurosci       Date:  2020-05-15       Impact factor: 6.167

2.  Blunted mGluR Activation Disinhibits Striatopallidal Transmission in Parkinsonian Mice.

Authors:  Qiaoling Cui; Jason E Pitt; Arin Pamukcu; Jean-Francois Poulin; Omar S Mabrouk; Michael P Fiske; Isabel B Fan; Elizabeth C Augustine; Katherine A Young; Robert T Kennedy; Rajeshwar Awatramani; C Savio Chan
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

3.  Modulation of GABAergic Synaptic Transmission by NMDA Receptors in the Dorsal Horn of the Spinal Cord.

Authors:  Benjamin Leonardon; Lou Cathenaut; Louise Vial-Markiewicz; Sylvain Hugel; Rémy Schlichter; Perrine Inquimbert
Journal:  Front Mol Neurosci       Date:  2022-07-04       Impact factor: 6.261

Review 4.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

5.  mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus.

Authors:  Yan-Gang Sun; Vanessa Rupprecht; Li Zhou; Rajan Dasgupta; Frederik Seibt; Michael Beierlein
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

Review 6.  Roles of Presynaptic NMDA Receptors in Neurotransmission and Plasticity.

Authors:  Abhishek Banerjee; Rylan S Larsen; Benjamin D Philpot; Ole Paulsen
Journal:  Trends Neurosci       Date:  2015-12-23       Impact factor: 13.837

7.  Inflammatory demyelination alters subcortical visual circuits.

Authors:  Sheila Espírito Santo Araújo; Henrique Rocha Mendonça; Natalie A Wheeler; Paula Campello-Costa; Kimberle M Jacobs; Flávia C A Gomes; Michael A Fox; Babette Fuss
Journal:  J Neuroinflammation       Date:  2017-08-18       Impact factor: 8.322

8.  The effect of NMDA-R antagonist, MK-801, on neuronal mismatch along the rat auditory thalamocortical pathway.

Authors:  Gloria G Parras; Catalina Valdés-Baizabal; Lauren Harms; Patricia T Michie; Manuel S Malmierca
Journal:  Sci Rep       Date:  2020-07-24       Impact factor: 4.379

9.  GABABR Modulation of Electrical Synapses and Plasticity in the Thalamic Reticular Nucleus.

Authors:  Huaixing Wang; Julie S Haas
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

10.  Spatial scale of receptive fields in the visual sector of the cat thalamic reticular nucleus.

Authors:  Cristina Soto-Sánchez; Xin Wang; Vishal Vaingankar; Friedrich T Sommer; Judith A Hirsch
Journal:  Nat Commun       Date:  2017-10-06       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.